Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001933031 | SCV002197185 | uncertain significance | not provided | 2023-08-16 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 1415337). This missense change has been observed in individual(s) with age-related macular degeneration (PMID: 34508573). This variant is present in population databases (no rsID available, gnomAD 0.007%). This sequence change replaces arginine, which is basic and polar, with glycine, which is neutral and non-polar, at codon 1044 of the CFH protein (p.Arg1044Gly). |
Fulgent Genetics, |
RCV002491882 | SCV002780406 | uncertain significance | Basal laminar drusen; Factor H deficiency; Hemolytic uremic syndrome, atypical, susceptibility to, 1; Age related macular degeneration 4 | 2021-11-24 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003452148 | SCV004177397 | uncertain significance | Hemolytic uremic syndrome, atypical, susceptibility to, 1 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003452151 | SCV004177398 | uncertain significance | Age related macular degeneration 4 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003452150 | SCV004177399 | uncertain significance | Basal laminar drusen | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003452149 | SCV004177400 | uncertain significance | Factor H deficiency | 2023-04-11 | criteria provided, single submitter | clinical testing |